Rani Therapeutics Holdings (RANI) Current Assets (2020 - 2026)

Rani Therapeutics Holdings has reported Current Assets for 7 years, with the latest figure at $56.5 million in Q2 2026.

• On a quarterly basis, Current Assets rose 410.46% year-over-year to $56.5 million in Q2 2026; TTM through Jun 2026 was $56.5 million, a 410.46% increase from a year earlier, with the FY2025 full-year figure at $53.3 million, up 79.27% from the prior year.
• Current Assets was $56.5 million for Q2 2026 at Rani Therapeutics Holdings, up from $47.1 million in the prior quarter.
• The five-year high for Current Assets was $109.3 million in Q1 2022, with the low at $5.0 million in Q3 2025.
• Average Current Assets over 5 years is $56.4 million, with a median of $52.1 million recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: Current Assets slumped 84.69% in 2025, then jumped 410.46% in 2026.
• Over 5 years, Current Assets stood at $100.9 million in 2022, then tumbled by 49.62% to $50.8 million in 2023, then sank by 41.5% to $29.7 million in 2024, then soared by 79.27% to $53.3 million in 2025, then rose by 6.01% to $56.5 million in 2026.
• The last three Current Assets figures came in at $56.5 million (Q2 2026), $47.1 million (Q1 2026), and $53.3 million (Q4 2025), per Business Quant data.